Literature DB >> 11028813

Expression of VCAM-1, ICAM-1, E-selectin, and P-selectin on endothelium in situ in patients with erythroderma, mycosis fungoides and atopic dermatitis.

V Sigurdsson1, I J de Vries, J Toonstra, I C Bihari, T Thepen, C A Bruijnzeel-Koomen, W A van Vloten.   

Abstract

BACKGROUND: Erythroderma may result from different causes. At present it is unclear whether the patho-mechanisms that lead to these different types of erythroderma are identical or different. Adhesion molecules and their ligands play a major role in endothelial-leukocyte interactions, which affect the binding, transmigration and infiltration of lymphocytes and mononuclear cells during inflammation, injury, or immunological stimulation. The aim of this study was to investigate the adhesion molecule expression on endothelial cells in erythroderma in situ.
METHODS: Snap-frozen skin biopsy specimens from 23 patients with erythroderma were studied. Eight had idiopathic erythroderma, 5 erythrodermic atopic dermatitis, 4 Sézary syndrome and 6 had erythroderma from miscellaneous causes. As a control we studied skin specimens from 10 patients with mycosis fungoides, 5 patients with atopic dermatitis and 5 healthy non-atopic volunteers. To determine adhesion molecule expression on endothelial cells in situ, sections were immuno-histochemically double stained with biotinylated Ulex Europaeus agglutinin 1 as a pan-endothelial cell marker, and for the adhesion molecules VCAM-1, ICAM-1, E-, and P-selectin. All double- and single-stained blood vessels in the dermis were counted.
RESULTS: Mean endothelial expression in erythroderma was as follows: VCAM-1 51.4%, ICAM-1 70.1%, E-selectin 43.5%, and P-selectin 52.6%. There was no statistical difference between different groups of erythroderma. Mean expression of all adhesion molecules tested, was in Sézary syndrome higher than in mycosis fungoides albeit not significant. In erythrodermic atopic dermatitis only VCAM-1 expression was significantly higher than in lesional skin of atopic dermatitis. No differences were observed in expression of the other three adhesion molecules.
CONCLUSIONS: There is no difference regarding adhesion molecule expression on endothelial cells between different types of erythroderma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11028813     DOI: 10.1034/j.1600-0560.2000.027009436.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  8 in total

1.  Exfoliative Dermatitis as a Para-neoplastic Syndrome of Prostate Adenocarcinoma: A Rare Case Report With Literature Review.

Authors:  Sayed Reshad Ghafouri; Abelardo Escriba-Omar; Inayatullah Wahdatyar; Noah Whited; Mohammad Nawar Hakim; Sumit Gaur; Fatma Dihowm
Journal:  Cancer Diagn Progn       Date:  2021-07-03

2.  Single-cell transcriptome profile of mouse skin undergoing antigen-driven allergic inflammation recapitulates findings in atopic dermatitis skin lesions.

Authors:  Juan Manuel Leyva-Castillo; Liang Sun; Shih-Ying Wu; Shira Rockowitz; Piotr Sliz; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2022-03-15       Impact factor: 14.290

3.  Biological properties of mud extracts derived from various spa resorts.

Authors:  Eliana Spilioti; Margarita Vargiami; Sophia Letsiou; Konstantinos Gardikis; Varvara Sygouni; Petros Koutsoukos; Ioanna Chinou; Eva Kassi; Paraskevi Moutsatsou
Journal:  Environ Geochem Health       Date:  2016-07-21       Impact factor: 4.609

4.  Breast cancer presenting as paraneoplastic erythroderma: an extremely rare case.

Authors:  Ioannis Protopsaltis; Aspasia Drossou; Ioannis Katsantonis; Nikolaos Roussos; Kassiani Manoludaki; Miltiadis Arvanitis; Athanasia Papazafiropoulou; Stavros Antonopoulos
Journal:  Case Rep Med       Date:  2014-09-11

5.  A Suspected Case of Silodosin-Induced Erythroderma.

Authors:  Annie Liu; Lyne Giroux
Journal:  Drug Saf Case Rep       Date:  2015-12

6.  East Indian Sandalwood Oil Is a Phosphodiesterase Inhibitor: A New Therapeutic Option in the Treatment of Inflammatory Skin Disease.

Authors:  Manju Sharma; Corey Levenson; John C Browning; Emily M Becker; Ian Clements; Paul Castella; Michael E Cox
Journal:  Front Pharmacol       Date:  2018-03-09       Impact factor: 5.810

7.  VCAM-1 blockade delays disease onset, reduces disease severity and inflammatory cells in an atopic dermatitis model.

Authors:  Lin Chen; Shao-xia Lin; Sanober Amin; Lut Overbergh; Giacomo Maggiolino; Lawrence S Chan
Journal:  Immunol Cell Biol       Date:  2010-01-12       Impact factor: 5.126

8.  Erythroderma: review of a potentially life-threatening dermatosis.

Authors:  Cynthia Okoduwa; W C Lambert; R A Schwartz; E Kubeyinje; A Eitokpah; Smeeta Sinha; W Chen
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.